Free Trial
→ An $8 trillion-dollar discovery 17,000 ft underwater (From Porter & Company) (Ad)tc pixel Free CORT Stock Alerts

Corcept Therapeutics (CORT) SEC Filings & 10K Form

Corcept Therapeutics logo
$69.36 -0.01 (-0.01%)
Closing price 04:00 PM Eastern
Extended Trading
$69.22 -0.14 (-0.20%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Corcept Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
09/04/2025
6:59 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
6:51 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
6:53 PM		Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
6:54 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
6:54 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
6:56 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025
3:09 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/02/2025
3:16 PM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2025
5:56 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2025
9:58 AM		Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2025
6:22 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025
6:19 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025
9:20 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2025
6:17 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
5:47 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
5:51 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
5:51 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
12:05 PM		Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2025
10:00 AM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2025
10:11 AM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2025
10:25 AM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/21/2025
6:10 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
6:10 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
6:11 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
6:14 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
7:12 PM		BlackRock, Inc. (Filed by)
Corcept Therapeutics (Subject)
Form SCHEDULE 13G/A
07/14/2025
3:36 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
7:05 AM		Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2025
11:21 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2025
7:35 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
7:36 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
7:39 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
12:52 PM		Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
1:01 PM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
1:09 PM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2025
5:26 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:53 PM		Cannon Gillian (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:39 PM		Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:40 PM		Alton Gregg H (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:41 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:42 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:44 PM		Corcept Therapeutics (Issuer)
Park Kimberly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:44 PM		Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:46 PM		Corcept Therapeutics (Issuer)
Murray Joshua M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:08 PM		BAKER G LEONARD JR (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
10:03 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2025
7:32 PM		Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:32 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:33 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:34 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:41 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
7:57 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
1:31 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2025
12:59 PM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2025
1:25 PM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
6:35 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
6:13 PM		Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
1:29 PM		Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
1:32 PM		Corcept Therapeutics (Subject)
MAHONEY DAVID L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
12:40 PM		Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2025
4:51 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
9:40 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2025
7:20 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
7:33 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
7:26 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
7:28 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
2:52 PM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/23/2025
6:41 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2025
6:09 AM		BlackRock, Inc. (Filed by)
Corcept Therapeutics (Subject)
Form SCHEDULE 13G/A
04/14/2025
4:58 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
9:07 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2025
7:01 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:08 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:15 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:20 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
2:13 PM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2025
2:23 PM		Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2025
2:00 PM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
7:05 AM		Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
5:55 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:07 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:07 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
7:30 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:30 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:54 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
10:02 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:15 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:53 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:58 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:34 PM		Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:38 PM		Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:44 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:27 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
12:59 PM		Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:47 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:37 AM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:18 AM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
3:18 PM		Corcept Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2025
3:06 PM		Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2025
4:23 PM		Corcept Therapeutics (Subject)
INGALLS & SNYDER LLC (Filed by)
Form SCHEDULE 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CORT) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel
Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...
Investors Alley | Sponsoredtc pixel
Warren Buffett Issues Cryptic Warning on U.S. Dollar
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...
Banyan Hill Publishing | Sponsoredtc pixel
2013 Bitcoin miner reveals his trading system (free)
While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...
Crypto Swap Profits | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsoredtc pixel
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsoredtc pixel
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel